The phenomenon of the down-regulation of epithelial marker ZO-1 and the concomitant elevation of mesenchymal markers such as N-cadherin and Vimentin suggested that the induction of TGF-β1 enables GBM cells to undergo epithelial-mesenchymal transition [20–22]. The gene discussed is CDH2; the disease is glioblastoma.